Why Is LL-37 Discussed for Chronic Infections Like Lyme Disease, and Is It Safe?

What Is LL-37?

LL-37 is a natural antimicrobial peptide your body produces as part of its first line of defense. It's the only human member of a family called cathelicidins, and it's found in white blood cells, skin, and the linings of the gut and airways.

LL-37 can:

• Kill bacteria, viruses, and fungi directly
• Help break down biofilms—protective layers some bacteria form
• Influence immune responses and inflammation
• Support wound healing

Why Is It Discussed for Lyme Disease?

Some people with persistent symptoms after Lyme disease, or other chronic infections, explore LL-37 because:

• Lab studies show it can disrupt biofilms, which some researchers believe may help bacteria persist
• It has broad antimicrobial activity

However, there are no clinical trials testing LL-37 for Lyme disease or chronic infections in people. Most evidence comes from lab and animal studies.

Is It Safe?

LL-37's safety as a supplement or injection is not established, and there are some important concerns:

• Inflammation: LL-37 can promote inflammation, not just reduce it
• Autoimmune links: Elevated LL-37 has been associated with autoimmune conditions like psoriasis, lupus, and rheumatoid arthritis
• Cancer: LL-37 has been linked to tumor growth in some cancers and tumor suppression in others
• Injection-related risks with unregulated products

Regulatory Status

LL-37 is not FDA-approved. Peptide regulations have changed several times in 2026, so a provider can help you understand current rules.

Evidence-Based Care for Lyme Disease

• Early Lyme disease is usually treated effectively with antibiotics like doxycycline
• Persistent symptoms after treatment (sometimes called post-treatment Lyme disease syndrome) are real, and research into causes and treatment is ongoing
• Work with a provider experienced in tick-borne illness to rule out other conditions and manage symptoms

For questions about peptides, talk with a provider: Talk to a Heva Specialist

The Bottom Line

LL-37 is a natural antimicrobial peptide with interesting lab research, which is why it's discussed for chronic infections like Lyme. But there are no human trials for these uses, and it carries real safety questions.